Exact Mass: 431.1957
Exact Mass Matches: 431.1957
Found 362 metabolites which its exact mass value is equals to given mass value 431.1957
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glenvastatin
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites
Fusarin C
Fusarin C is produced by many Fusarium species in infected corn. Production by many Fusarium subspecies in infected corn. D009676 - Noxae > D009153 - Mutagens
Lafutidine
Lafutidine is a histamine H2-receptor antagonist that inhibits histamine-stimulated gastric acid secretion. Due to the resulting reduction in gastric volume and acidity, lafutidine can be used to treat ulcers and reflux. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
(3S,11R,11aR)-3-Methoxy-4,9-dimethyl-8beta-hydroxy-3beta-[[(2S,4S)-4-methyl-5-oxotetrahydrofuran]-2-yl]-2,3,5,6,7,8-hexahydrospiro[1H-cyclopenta[b]pyrrolo[1,2-a]azepine-11(10H),2(5H)-furan]-5,10-dione
4-methoxy-3-methyl-5-[(2Z,3aR)-3ac,10c-epoxy-1t-methyl-8t-((2S)-4c-methyl-5-oxo-tetrahydrofuran-2r-yl)-(3ar,10at,10bt)-decahydro-2H-furo[3,2-c]pyrrolo[1,2-a]azepin-2-ylidene]-5H-furan-2-one|oxyprotostemonine
Lafutidine
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Ala Asp Ile Asn
Ala Asp Leu Asn
Ala Asp Asn Ile
Ala Asp Asn Leu
Ala Asp Gln Val
Ala Asp Val Gln
Ala Glu Asn Val
Ala Glu Val Asn
Ala Ile Asp Asn
Ala Ile Asn Asp
Ala Leu Asp Asn
Ala Leu Asn Asp
Ala Asn Asp Ile
Ala Asn Asp Leu
Ala Asn Glu Val
Ala Asn Ile Asp
Ala Asn Leu Asp
Ala Asn Val Glu
Ala Gln Asp Val
Ala Gln Val Asp
Ala Val Asp Gln
Ala Val Glu Asn
Ala Val Asn Glu
Ala Val Gln Asp
Cys Gly Pro Arg
Cys Gly Arg Pro
Cys Pro Gly Arg
Cys Pro Arg Gly
Cys Arg Gly Pro
Cys Arg Pro Gly
Asp Ala Ile Asn
Asp Ala Leu Asn
Asp Ala Asn Ile
Asp Ala Asn Leu
Asp Ala Gln Val
Asp Ala Val Gln
Asp Gly Ile Gln
Asp Gly Leu Gln
Asp Gly Gln Ile
Asp Gly Gln Leu
Asp Ile Ala Asn
Asp Ile Gly Gln
Asp Ile Asn Ala
Asp Ile Gln Gly
Asp Leu Ala Asn
Asp Leu Gly Gln
Asp Leu Asn Ala
Asp Leu Gln Gly
Asp Asn Ala Ile
Asp Asn Ala Leu
Asp Asn Ile Ala
Asp Asn Leu Ala
Asp Gln Ala Val
Asp Gln Gly Ile
Asp Gln Gly Leu
Asp Gln Ile Gly
Asp Gln Leu Gly
Asp Gln Val Ala
Asp Val Ala Gln
Asp Val Gln Ala
Glu Ala Asn Val
Glu Ala Val Asn
Glu Gly Ile Asn
Glu Gly Leu Asn
Glu Gly Asn Ile
Glu Gly Asn Leu
Glu Gly Gln Val
Glu Gly Val Gln
Glu Ile Gly Asn
Glu Ile Asn Gly
Glu Leu Gly Asn
Glu Leu Asn Gly
Glu Asn Ala Val
Glu Asn Gly Ile
Glu Asn Gly Leu
Glu Asn Ile Gly
Glu Asn Leu Gly
Glu Asn Val Ala
Glu Gln Gly Val
Glu Gln Val Gly
Glu Val Ala Asn
Glu Val Gly Gln
Glu Val Asn Ala
Glu Val Gln Gly
Gly Cys Pro Arg
Gly Cys Arg Pro
Gly Asp Ile Gln
Gly Asp Leu Gln
Gly Asp Gln Ile
Gly Asp Gln Leu
Gly Glu Ile Asn
Gly Glu Leu Asn
Gly Glu Asn Ile
Gly Glu Asn Leu
Gly Glu Gln Val
Gly Glu Val Gln
Gly Ile Asp Gln
Gly Ile Glu Asn
Gly Ile Asn Glu
Gly Ile Gln Asp
Gly Leu Asp Gln
Gly Leu Glu Asn
Gly Leu Asn Glu
Gly Leu Gln Asp
Gly Asn Glu Ile
Gly Asn Glu Leu
Gly Asn Ile Glu
Gly Asn Leu Glu
Gly Pro Cys Arg
Gly Pro Arg Cys
Gly Gln Asp Ile
Gly Gln Asp Leu
Gly Gln Glu Val
Gly Gln Ile Asp
Gly Gln Leu Asp
Gly Gln Val Glu
Gly Arg Cys Pro
Gly Arg Pro Cys
Gly Val Glu Gln
Gly Val Gln Glu
Ile Ala Asp Asn
Ile Ala Asn Asp
Ile Asp Ala Asn
Ile Asp Gly Gln
Ile Asp Asn Ala
Ile Asp Gln Gly
Ile Glu Gly Asn
Ile Glu Asn Gly
Ile Gly Asp Gln
Ile Gly Glu Asn
Ile Gly Asn Glu
Ile Gly Gln Asp
Ile Asn Ala Asp
Ile Asn Asp Ala
Ile Asn Glu Gly
Ile Asn Gly Glu
Ile Gln Asp Gly
Ile Gln Gly Asp
Leu Ala Asp Asn
Leu Ala Asn Asp
Leu Asp Ala Asn
Leu Asp Gly Gln
Leu Asp Asn Ala
Leu Asp Gln Gly
Leu Glu Gly Asn
Leu Glu Asn Gly
Leu Gly Asp Gln
Leu Gly Glu Asn
Leu Gly Asn Glu
Leu Gly Gln Asp
Leu Asn Ala Asp
Leu Asn Asp Ala
Leu Asn Glu Gly
Leu Asn Gly Glu
Leu Gln Asp Gly
Leu Gln Gly Asp
Asn Ala Asp Ile
Asn Ala Asp Leu
Asn Ala Glu Val
Asn Ala Ile Asp
Asn Ala Leu Asp
Asn Ala Val Glu
Asn Asp Ala Ile
Asn Asp Ala Leu
Asn Asp Ile Ala
Asn Asp Leu Ala
Asn Glu Ala Val
Asn Glu Gly Ile
Asn Glu Gly Leu
Asn Glu Ile Gly
Asn Glu Leu Gly
Asn Glu Val Ala
Asn Gly Glu Ile
Asn Gly Glu Leu
Asn Gly Ile Glu
Asn Gly Leu Glu
Asn Ile Ala Asp
Asn Ile Asp Ala
Asn Ile Glu Gly
Asn Ile Gly Glu
Asn Leu Ala Asp
Asn Leu Asp Ala
Asn Leu Glu Gly
Asn Leu Gly Glu
Asn Pro Thr Thr
Asn Thr Pro Thr
Asn Thr Thr Pro
Asn Val Ala Glu
Asn Val Glu Ala
Pro Cys Gly Arg
Pro Cys Arg Gly
Pro Gly Cys Arg
Pro Gly Arg Cys
Pro Asn Thr Thr
Pro Gln Ser Thr
Pro Gln Thr Ser
Pro Arg Cys Gly
Pro Arg Gly Cys
Pro Ser Gln Thr
Pro Ser Thr Gln
Pro Thr Asn Thr
Pro Thr Gln Ser
Pro Thr Ser Gln
Pro Thr Thr Asn
Gln Ala Asp Val
Gln Ala Val Asp
Gln Asp Ala Val
Gln Asp Gly Ile
Gln Asp Gly Leu
Gln Asp Ile Gly
Gln Asp Leu Gly
Gln Asp Val Ala
Gln Glu Gly Val
Gln Glu Val Gly
Gln Gly Asp Ile
Gln Gly Asp Leu
Gln Gly Glu Val
Gln Gly Ile Asp
Gln Gly Leu Asp
Gln Gly Val Glu
Gln Ile Asp Gly
Gln Ile Gly Asp
Gln Leu Asp Gly
Gln Leu Gly Asp
Gln Pro Ser Thr
Gln Pro Thr Ser
Gln Ser Pro Thr
Gln Ser Thr Pro
Gln Thr Pro Ser
Gln Thr Ser Pro
Gln Val Ala Asp
Gln Val Asp Ala
Gln Val Glu Gly
Gln Val Gly Glu
Arg Cys Gly Pro
Arg Cys Pro Gly
Arg Gly Cys Pro
Arg Gly Pro Cys
Arg Pro Cys Gly
Arg Pro Gly Cys
Ser Pro Gln Thr
Ser Pro Thr Gln
Ser Gln Pro Thr
Ser Gln Thr Pro
Ser Thr Pro Gln
Ser Thr Gln Pro
Thr Asn Pro Thr
Thr Asn Thr Pro
Thr Pro Asn Thr
Thr Pro Gln Ser
Thr Pro Ser Gln
Thr Pro Thr Asn
Thr Gln Pro Ser
Thr Gln Ser Pro
Thr Ser Pro Gln
Thr Ser Gln Pro
Thr Thr Asn Pro
Thr Thr Pro Asn
Val Ala Asp Gln
Val Ala Glu Asn
Val Ala Asn Glu
Val Ala Gln Asp
Val Asp Ala Gln
Val Asp Gln Ala
Val Glu Ala Asn
Val Glu Gly Gln
Val Glu Asn Ala
Val Glu Gln Gly
Val Gly Glu Gln
Val Gly Gln Glu
Val Asn Ala Glu
Val Asn Glu Ala
Val Gln Ala Asp
Val Gln Asp Ala
Val Gln Glu Gly
Val Gln Gly Glu
Quinagolide hydrochloride
D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2]. Quinagolide hydrochloride (CV205-502 hydrochloride) is a selective and orally active dopamine D2 receptor agonist. Quinagolide hydrochloride is an inhibitor of prolactin. Quinagolide hydrochloride down-regulates AKT levels and its phosphorylation. Quinagolide hydrochloride shows antitumor effects, it can be used for the research of cancer[1][2].
Ethaverine hydrochloride
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor C93038 - Cation Channel Blocker
Succinimidyl (2R)-6-(Tetrahydro-2H-pyran-2-yloxy)-2,5,7,8-tetramethylchroman-2-carboxylate
sodium,1-dodecoxy-4-(2-hydroxyethylamino)-1,4-dioxobutane-2-sulfonate
Esreboxetine succinate
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent